levers semaglutide Retatrutide, a triple agonist, delivered 30.3% weight loss at two years in Phase 3. The headlines state: → 70 lbs average loss on 12mg at 80 weeks (28.3% of body weight) → The science of losing fat
Description
10.1016/j.cmet.2020.12.009 53 SatoA
It is widely used to treat Type 2 diabetes in adults and off-label for weight loss
Physical activity helps maintain muscle tone throughout the body, including the muscles of the intestinal tract
J.AlbrechtsenN
Some people fine-tune: e.g., a patient might feel best on 1.7 mg Wegovy and not go to 2.4 because 1.7 mg curbs appetite adequately with tolerable side effects and 2.4 mg adds too much nausea
